-
Adolescent Mental Health
https://braincanada.ca/funded-grants/adolescent-mental-healthMost mental disorders begin in adolescence; however, there are many gaps in our understanding of youth mental health. Project Overview Most mental disorders begin in adolescence; however, there are many gaps in our understanding of youth mental health. Clinical and policy gaps arise from our...
-
Advanced multi-functional in vivo retinal imaging for ocular oncology
https://braincanada.ca/funded-grants/advanced-multi-functional-in-vivo-retinal-imaging-for-ocular-oncologyNeed for project: Choroidal tumors present clinicians with many challenges. The overlap between clinical and imaging findings combined with the difficulty of performing choroidal biopsies can create diagnostic dilemmas. Project Overview Need for project: Choroidal tumors present clinicians with...
-
Advanced Multi-modal neuroimaging Platform for Psychiatry
https://braincanada.ca/funded-grants/advanced-multi-modal-neuroimaging-platform-for-psychiatryMental health disorders impact one in four Canadians, yet our understanding of the brain and its relationship to mental illness is dwarfed by what we do not know. Project Overview Mental health disorders impact one in four Canadians, yet our understanding of the brain and its relationship to mental...
-
Advanced Optical Nanoscopy Platform for Neuroscience
https://braincanada.ca/funded-grants/advanced-optical-nanoscopy-platform-for-neuroscienceUnderstanding how the brain works at the molecular level is one of the outmost important challenges. Tiny structures inside brain cells are constantly changing to support learning, memory, and behavior, in health and disease. To see and study these structures, scientists use powerful microscopes...
-
Advanced pharmacokinetics and pharmacodynamics for phase Ib/IIa trial of repurposed enoxacin therapy for patients with ALS
https://braincanada.ca/funded-grants/advanced-pharmacokinetics-and-pharmacodynamics-for-phase-ib-iia-trial-of-repurposed-enoxacin-therapy-for-patients-with-alsAmyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, primarily affecting motor neurons, for which there are currently no adequately effective therapies. Project Overview Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, primarily affecting...
-
Advancing biology based therapies for rhabdoid brain tumours
https://braincanada.ca/funded-grants/advancing-biology-based-therapies-for-rhabdoid-brain-tumoursRhabdoid brain tumours are the most common brain cancers in infants. Project Overview Rhabdoid brain tumours are the most common brain cancers in infants. Usually these aggressive tumours are treated with intense chemotherapy and radiation therapy, which can have serious side effects. Dr Annie...
-
Advancing Brain Cancer Research
https://braincanada.ca/about/news-updates/advancing-brain-cancer-researchPHOTO: Dr. Robert Vanner (left) and Dr. Sheila Singh, recipients of the 2025 Translational Research Grants in Brain Cancer. Brain Canada and Cancer Research Society (CRS) are advancing brain cancer research through collaborative innovation and translational impact As part of their ongoing...
-
Advancing Brain Research Through Spatial Histology
https://braincanada.ca/funded-grants/advancing-brain-research-through-spatial-histologyThe Histology Innovation Platform at McGill University is a specialized facility that helps scientists study the brain at a cellular level to better understand neurological diseases like Alzheimer’s, brain cancer, and epilepsy. Project Overview The Histology Innovation Platform at McGill...
-
Advancing Health Research Solutions in Saskatchewan
https://braincanada.ca/about/news-updates/advancing-health-research-solutions-in-saskatchewanSaskatchewan Health Research Foundation (SHRF), Brain Canada, Jim Pattison Children’s Hospital Foundation (JPCHF), Alzheimer Society of Saskatchewan (ASOS) and Lung Saskatchewan are proud to share that we’re investing $2.7 million in peer-reviewed, home-grown research solutions addressing...
-
Advancing towards treatment for Huntington’s Disease
https://braincanada.ca/about/news-updates/advancing-towards-treatment-for-huntington-s-diseaseGroup of cells expressing mutant huntingtin (in red) in vitro. Yellow puncta are aggregates of mutant huntingtin and p62, a protein involved in the clearance of protein aggregates. Huntington disease (HD) is an inherited disorder that causes progressive malfunctioning and death of parts of the...